Disclosure 0000907654-26-000108-2

SEC FORM 4

$27,300.00

Oruka Therapeutics, Inc. (ORKA)

Acquisition (code M) of 3,500 shares at $7.80 per share.

Reporting Person Goncalves Joana · Officer Title Chief Medical Officer · Transaction Code M

Traded Oct 15, 2026 · Disclosed Oct 15, 2026

Source: SEC Form 4 · 0000907654-26-000108 · filed 2026-10-15 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Oruka Therapeutics, Inc. (ORKA)." Disclosed 2026-10-15. https://desqlong.com/cards/0000907654-26-000108-2 (retrieved 2026-10-16).